Erythrocyte-derived particles for near infrared phototherapy of port wine stains.

用于鲜红斑痣近红外光疗的红细胞衍生颗粒。

• 批准号: 10580669
• 负责人: BAHMAN ANVARI
• 金额: $ 51.52万
• 依托单位: UNIVERSITY OF CALIFORNIA RIVERSIDE
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-03-10 至 2027-02-28
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10580669
• 关键词: Animal Model; Animals; Biodistribution; Biological Assay; Blood; Blood Vessels; Blood capillaries; Characteristics; Cholesterol; Circulation; Clinical; Coagulation Process; Darkness; Dermal; Dermatologic; Deterioration; Development; Dorsal; Dose; Dyes; Ensure; Erythrocytes; Euthanasia; Excision; Fluorescence; Half-Life; Hemoglobin; Histologic; Histology; Hour; Human; Indocyanine Green; Injections; Injury; Knowledge; Laser Speckle Imaging; Lasers; Length; Lesion; Light; Light Coagulation; Measurement; Measures; Melanins; Membrane; Modeling; Mus; National Institute of Arthritis, and Musculoskeletal, and Skin Diseases; New Zealand; Optics; Organ; Oryctolagus cuniculus; Outcome; Patients; Penetration; Phosphatidylserines; Phototherapy; Physiologic pulse; Pigmentation physiologic function; Pigments; Port-Wine Stain; Protocols documentation; Quality Control; Reproducibility; Research Personnel; Signal Transduction; Site; Skin; Stains; Temperature; Therapeutic; Time; Tissues; Transgenic Mice; Treatment Effectiveness; Treatment Efficacy; Visualization; absorption; chromophore; clinical application; effective therapy; effectiveness evaluation; efficacy evaluation; experimental study; fluorescence imaging; innovation; irradiation; malformation; novel therapeutic intervention; particle; patient population; prevent; psychologic; response; skin color; skin disorder; standard care; zeta potential

Port wine stain (PWS) is a congenital and progressive malformations of the dermal capillaries. Pulsed dye laser (POL) irradiation in the visible wavelength range of 585-600 nm remains as the gold standard of treatment. The underlying treatment principle is based on the absorption of POL light by hemoglobin to induce irreversible photothermal coagulation of the vasculature. However, therapeutic efficacy with POLs remains limited due to insufficient penetration of light in skin, and non-specific absorption by the epidermal melanin pigments. Clinically acceptable outcomes are achieved in only about 20% of patients with diminishing returns beyond five treatment sessions. Our long-term objective is the development of a new therapeutic approach based on intravascular administration of optical micro-particles, fabricated from erythrocytes, as targets for pulsed near infrared (NIR) laser treatment at 755 nm. These micro-particles are doped with indocyanine green (ICG), the only FOA-approved NIR chromophore. The underlying premise is based on reduced absorption of light by melanin, strong ICG absorption, and availability of dermatological lasers at 755 nm. A particularly innovative feature of these micro-particles is that their membrane is enriched with cholesterol to prevent the flipping of phosphatidylserine from the inner to the outer leaflet of the membrane, which would otherwise serve as a signal for removal of the particles from the vasculature. We refer to these micro-particles as c⁺- µNETs. By using c⁺-µNETs, we aim to prolong the circulation time of ICG, and increase its availability in the lesion vasculature so that more sites can be treated during a given session, ultimately leading to minimal therapeutic sessions to clear the stain. Another innovative aspect is the use of transgenic mice whose melanin content can be varied in a controllable manner to simulate the epidermal response of PWS with different pigmentations to 755 nm laser irradiation. We will use these mice to determine the threshold values of the laser radiant exposures for epidermal injury and blood vessels photocoagulation in conjunction with c⁺-µNETs. We will also use a rabbit model to characterize the circulation and biodistribution dynamics of c⁺-µNETs, determine the therapeutic window of time when using c⁺-µNETs, and evaluate the vascular response as it relates to laser irradiation parameters and dose of c⁺-µNETs. SA 1: Fabricate and characterize c⁺-µNETs. SA 2: Characterize the circulation and biodistribution dynamics of c⁺-µNETs. SA 3: Evaluate the therapeutic efficacy of c⁺-µNETs in conjunction with pulsed NIR laser irradiation. A key outcome of our proposed studies is that we will know the maximum length of time over which effective blood vessels photocoagulation can be achieved when using c⁺-µNETs, in addition to finding the appropriate radiant exposure levels for vascular photocoagulation in skins with various pigmentations. This knowledge is not currently available, but is essential towards development of safe and effective protocols for laser treatment of PWS patients. Proposed studies are consistent with the scientific themes of NIAMS in developing effective therapies for PWS.

葡萄酒斑痣（PWS）是一种先天性和进行性皮肤毛细血管畸形。